Caveolin-1 and Pancreatic Cancer Prognosis
Author Information
Author(s): Suzuoki M, Miyamoto M, Kato K, Hiraoka K, Oshikiri T, Nakakubo Y, Fukunaga A, Shichinohe T, Shinohara T, Itoh T, Kondo S, Katoh H
Primary Institution: Hokkaido University Graduate School of Medicine
Hypothesis
The study investigates the relationship between caveolin-1 expression and clinical outcomes in pancreatic ductal adenocarcinoma.
Conclusion
Caveolin-1 overexpression is associated with tumor progression and indicates a poor prognosis for patients undergoing surgical resection for pancreatic carcinoma.
Supporting Evidence
- Positive caveolin-1 expression was found in 32 out of 79 tumors (40.5%).
- Caveolin-1 expression correlated with tumor diameter and histopathologic grade.
- Patients with positive caveolin-1 expression had a significantly poorer prognosis.
Takeaway
Caveolin-1 is a protein that can help doctors understand how aggressive pancreatic cancer is; if there's a lot of it, the cancer might be worse.
Methodology
The study used immunohistochemistry to assess caveolin-1 expression in surgically resected specimens from patients with pancreatic adenocarcinoma.
Limitations
The study is retrospective and may not account for all variables affecting prognosis.
Participant Demographics
44 men and 35 women with a median age of 63 years.
Statistical Information
P-Value
P=0.0008
Confidence Interval
95% CI, 1.043–3.390
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website